To view the PDF file, sign up for a MySharenet subscription.

BRITISH AMERICAN TOBACCO PLC - Publication of Final Terms

Release Date: 14/08/2017 16:30
Code(s): BTI     PDF:  
Wrap Text
Publication of Final Terms

British American Tobacco p.l.c.
Incorporated in England and Wales
(Registration number: 03407696)
Short name: BATS
Share code: BTI
ISIN number: GB0002875804
("British American Tobacco p.l.c." or "the Company")



Publication of Final Terms
The following final terms (the “Final Terms”) are available for viewing:

Final Terms for

(i)     B.A.T Capital Corporation’s €1,100,000,000 Floating Rate Guaranteed Notes due 2021
        (the “2021 Notes”);

(ii)    B.A.T Capital Corporation’s €750,000,000 1.125 per cent. Guaranteed Notes due 2023
        (the “2023 Notes”);

(iii)   B.A.T Capital Corporation’s £450,000,000 2.125 per cent. Guaranteed Notes due 2025
        (the “2025 Notes”); and

(iv)    B.A.T. International Finance p.l.c.’s €1,250,000,000 2.250 per cent. Guaranteed Notes due
        2030 (the “2030 Notes”, and together with the 2021 Notes, the 2023 Notes and 2025
        Notes, the “Notes”),

issued pursuant to the prospectus dated 31 May 2017 (as supplemented by the supplemental
prospectus dated 8 August 2017) (together, the “Prospectus”) in connection with the
£25,000,000,000 Euro Medium Term Note Programme of B.A.T. International Finance p.l.c., B.A.T
Capital Corporation, British American Tobacco Holdings (The Netherlands) B.V. and B.A.T.
Netherlands Finance B.V. (as Issuers) and British American Tobacco p.l.c. and each of the Issuers
(except where it is the relevant Issuer) (as Guarantors).

The Final Terms for the Notes contain the final terms of the Notes. The Final Terms of the Notes
must be read in conjunction with the Prospectus, which constitutes a base prospectus for the
purposes of the Prospectus Directive (Directive 2003/71/EC), as amended.

To view the full documents, please paste the following URLs into the address bar of your browser.

http://www.rns-pdf.londonstockexchange.com/rns/9497N_-2017-8-14.pdf

http://www.rns-pdf.londonstockexchange.com/rns/9497N_1-2017-8-14.pdf

http://www.rns-pdf.londonstockexchange.com/rns/9497N_2-2017-8-14.pdf

http://www.rns-pdf.londonstockexchange.com/rns/9497N_3-2017-8-14.pdf

The Final Terms have been submitted to the National Storage Mechanism and will shortly be
available for inspection at: www.hemscott.com/nsm.do

Enquiries

British American Tobacco Press Office
+44 (0)20 7845 2888 (24 hours)| @BATPress


Investor Relations
Mike Nightingale/Rachael Brierley/Sabina Marshman
+44 (0)20 7845 1180/1519/1781
British American Tobacco p.l.c.
Globe House
4 Temple Place
London WC2R 2PG



14 August 2017



DISCLAIMER – INTENDED ADDRESSEES

Please note that the information contained in the Final Terms (when read together with the
Prospectus) may be addressed to and/or targeted at persons who are residents of particular
countries (specified in the Prospectus) only and is not intended for use and should not be relied
upon by any person outside these countries and/or to whom the offer contained in the Final Terms
and the Prospectus is not addressed. Prior to relying on the information contained in the Final
Terms or the Prospectus, you must ascertain from the Prospectus whether or not you are one of
the intended addressees of the information contained therein.

The Notes have not been registered under the Securities Act or any relevant securities laws of any
state of the United States, and may not be offered or sold in the United States absent registration
or pursuant to an exemption from, or in a transaction not subject to, the registration requirements
of the Securities Act.

Your right to access this service is conditional upon complying with the above requirement.



Sponsor: UBS South Africa (Pty) Ltd

Date: 14/08/2017 04:30:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story